| Literature DB >> 35557911 |
Piaopiao Chen1, Pingyue Hu2, Ke Huang2, Erica Sawyer1, Ke Sun1, Binwu Ying1, Xiawei Wei1, Jia Geng1.
Abstract
The development of simple, sensitive and cost-effective methods for specific nucleic acid detection has attracted tremendous attention due to its importance to the early diagnosis of genetic diseases and to biodefense applications. In this work, we demonstrated a fluorescent turn-off mode DNA assay based on l-cysteine-modulated synthesis of CdTe quantum dots (CdTe QDs), horseradish peroxidase-mimicking G-quadruplex-hemin-K+ complex controlled oxidation of l-cysteine to cystine, and catalyzed hairpin assembly (CHA)-assisted signal amplification. After the addition of target DNA, the CHA signal amplification reaction was triggered and numerous H1-H2 double-stranded DNA were formed, initiating the release of G-quadruplex sequences in H2 simultaneously. Thus, the degree of inhibition of the synthesis of CdTe QDs is proportional to the concentration of the G-quadruplex sequence in this method. In contrast, when the target DNA was absent, the CHA could not be triggered, and the fluorescence signal was high due to the remaining intact l-cysteine. Under optimal experimental conditions, the homogeneous fluorescence method achieved the detection of HIV DNA with a linear range from 0.1 pM to 1 nM and a detection limit of 0.12 pM. This novel biosensor exhibits excellent specificity in differentiating DNA sequences with a single-base and two-base mismatch. To the best of our knowledge, this a label-free and highly sensitive bioassay utilizing CHA-assisted signal amplification and G-quadruplex control of in situ synthesis of CdTe QDs strategy was not reported in previous. Thus, this proposed strategy is anticipated to find use in basic biochemical research and clinical diagnosis. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35557911 PMCID: PMC9091423 DOI: 10.1039/c8ra08296k
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Sequences of oligonucleotides used in the study
| Name | Sequence (5′-3′) |
|---|---|
| G1 (G-quadruplex) | GGGTTTTGGGTTTTGGGTTTTGGG |
| Target DNA | AGTCAGTGTGGAAAATCTCTAGC |
| H1 (hairpin probe 1) | GCTAGAGATTTTCCACACTGACTTCTCTAGCGGGTTTTGGGTTTTAGTCAGTGTGGAAAA |
| H2 (hairpin probe 2) | CTGACTAAAACCCAAAACCCGCTAGAGAAGTCAGTGTGGAAAATCTCTAGCGGGTTTTGGGTTTTGGGTTTTGGG |
| Single-base mismatch | AGTCAGTGTGGT̲AAATCTCTAGC |
| Two-base mismatch | AGTCAGTC̲TGGAAAT̲TCTCTAGC |
| Non-complementary | GCATGTATATTCTTCATCAATAG |
Scheme 1Schematic illustration of the label-free and homogeneous fluorescence DNA assay based on the G-quadruplex-controlled oxidation of l-cysteine and CHA-assisted signal amplification.
Fig. 1(A) TEM of CdTe QDs, (B) UV-vis spectrum of CdTe QDs, (C) fluorescence spectrum under different conditions. (a) l-Cys only; (b) G-quadruplex–hemin–K+ + l-Cys, (D) experimental feasibility verification under different conditions.
Fig. 2Analytical performance of the proposed label-free and homogeneous strategy for DNA detection. (A) Fluorescence spectra of obtained CdTe QDs in the presence of various DNA concentrations. (B) Calibration curve for DNA detection. Inset: the linearity of fluorescence intensity with respect to logarithmic DNA concentrations ranging from 0.1 pM to 1 nM. Error bars were estimated from three replicate measurements.
Fig. 3Nucleic acid sequence selectivity of the proposed label-free and homogeneous strategy using different DNA targets at same concentration of 1 nM. (A) Fluorescence spectra of obtained CdTe QDs. (B) The (F0 − F)/F0 in the presence of target DNA with different base mismatches. F0 and F represent the fluorescence signal of the solution containing H1 and H2 in the absence and presence of 1 nM target DNA, respectively.
The detection of target DNA in spiked human serum samples
| Sample | Added, pM | Found | Recovery | RSD |
|---|---|---|---|---|
| 1% serum | 1.00 | 0.93 ± 0.05 | 93 | 6.2 |
| 10 | 9.6 ± 0.15 | 96 | 3.8 | |
| 100 | 104 ± 5 | 104 | 4.1 | |
| 1000 | 997 ± 18 | 99 | 3.3 |
Mean and standard deviation of results (n = 3).
Recovery (%) = (CFound/CAdded) × 100%.
Relative standard deviation.